Related Experiment Video
Updated: Feb 22, 2026

Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
Increased risk organ transplantation in the pediatric population
Sean M Wrenn1,2, Peter W Callas1,2, Trishul Kapoor1,3
1Department of Surgery, Larner College of Medicine at The University of Vermont, Burlington, VT, USA.
Insights
Organs from deceased donors with infectious disease risk (IRD) show similar patient and graft survival rates in pediatric kidney and liver transplants. Increased utilization of IRD organs could improve transplant access and reduce wait times.
Area of Science:
- Transplantation immunology
- Infectious disease in transplantation
- Pediatric surgery
Background:
- Organs from donors with infectious disease risk (IRD) are underutilized, especially in pediatric transplant recipients, due to perceived risks of viral transmission (HIV, Hepatitis B/C).
- This underutilization contributes to longer wait times and associated morbidity/mortality for pediatric patients awaiting organ transplantation.
Purpose of the Study:
- To evaluate the outcomes of pediatric kidney and liver transplants utilizing organs from donors with infectious disease risk (IRD) compared to standard risk (SRD) donors.
- To analyze organ acceptance rates, waitlist times, and infectious transmissions associated with IRD organ utilization in pediatric recipients.
Main Methods:
- Retrospective analysis of the United Network for Organ Sharing (UNOS) database for pediatric renal and hepatic transplants (2004-2008).
- Comparison of patient and graft survival between IRD and SRD organs using proportional hazards regression.
- Analysis of organ acceptance rates, waitlist duration, and reported infectious transmissions.
Main Results:
- No statistically significant differences in patient or graft survival were observed between IRD and SRD kidney or liver transplants.
- Organ acceptance rates for IRD kidneys (1.5%) and livers (1.99%) were lower than for SRD organs (4.82% and 4.51%, respectively).
- A single bloodborne pathogen transmission was reported across 7797 unique transplants from 2008-2015, indicating a low transmission risk.
Conclusions:
- Pediatric kidney and liver transplants using IRD organs demonstrate comparable survival outcomes to those using SRD organs.
- Increasing the utilization of IRD organs could significantly improve access to transplantation for pediatric patients.
- Wider acceptance of IRD organs may reduce transplant wait times and mitigate risks associated with prolonged waitlist periods.
Abstract:
IRD organs are classified by the Public Health Service to be at above-average risk for harboring human immunodeficiency virus, hepatitis C, and hepatitis B. Traditionally underutilized, there exists even greater reluctance for their use in pediatric patients. We performed a retrospective analysis via the United Network for Organ Sharing database of all pediatric renal and hepatic transplants performed from 2004 to 2008 in the United States. Primary outcomes were patient and graft survival. Proportional hazards regression was performed to control for potentially confounding factors. Waitlist time, organ acceptance rates, and infectious transmissions were analyzed. There were 1830 SRD renal, 92 IRD renal, 1695 SRD hepatic, and 59 IRD hepatic transplants. There were no statistically significant differences in allograft or patient survival in either group. Acceptance rates of IRD organs were lower for kidney (1.5% IRD vs 4.82% SRD) and liver (1.99% IRD vs 4.51% SRD). One transmission of a bloodborne pathogen involving a pediatric recipient out of 7797 unique transplants was reported from 2008 to 2015. IRD organs appear to have equivalent outcomes. Increasing their utilization may improve access to transplant while decreasing wait times and circumventing waitlist morbidity and mortality.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Kidney Transplant III: Nursing Management
Pharmacokinetics in Pediatric Patients: Drug Excretion

